Nuzenio

Sclc Clinical Trials

Sclc Clinical Trials news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 6 latest news signals 6 publisher sources 100/100 entity strength

Latest news

SystImmune doses first patient in Phase III trial for ES-SCLC - Clinical Trials ArenaClinical Trials Arena · Thu, 06 Aug 2026 10:25:17 GMTLurbinectedin Second-Line SCLC Indication to Be Withdrawn After LAGOON - Targeted OncologyTargeted Oncology · Wed, 05 Aug 2026 14:09:27 GMTWithdrawal Planned for Second-Line Lurbinectedin in SCLC Indication - CancerNetworkCancerNetwork · Wed, 05 Aug 2026 14:09:23 GMTSystImmune Announces First Patient Dosed in Global Phase 3 Trial of BL-M14D1 in First-Line Extensive-Stage Small Cell Lung Cancer - PR NewswirePR Newswire · Wed, 05 Aug 2026 12:00:00 GMTRecon: Lilly to broaden expanded access for unapproved obesity drug; Jazz to withdraw second-line SCLC indication for Zepzelca - RAPSRAPS · Tue, 04 Aug 2026 20:19:00 GMTTREASURE Trial Raises Safety Concerns for Thoracic Radiotherapy With Atezolizumab in ES-SCLC - OncodailyOncodaily · Mon, 03 Aug 2026 17:36:53 GMT

Timeline

Thu, 06 Aug 2026 10:25:17 GMTSystImmune doses first patient in Phase III trial for ES-SCLC - Clinical Trials Arena
Wed, 05 Aug 2026 14:09:27 GMTLurbinectedin Second-Line SCLC Indication to Be Withdrawn After LAGOON - Targeted Oncology
Wed, 05 Aug 2026 14:09:23 GMTWithdrawal Planned for Second-Line Lurbinectedin in SCLC Indication - CancerNetwork
Wed, 05 Aug 2026 12:00:00 GMTSystImmune Announces First Patient Dosed in Global Phase 3 Trial of BL-M14D1 in First-Line Extensive-Stage Small Cell Lung Cancer - PR Newswire
Tue, 04 Aug 2026 20:19:00 GMTRecon: Lilly to broaden expanded access for unapproved obesity drug; Jazz to withdraw second-line SCLC indication for Zepzelca - RAPS
Mon, 03 Aug 2026 17:36:53 GMTTREASURE Trial Raises Safety Concerns for Thoracic Radiotherapy With Atezolizumab in ES-SCLC - Oncodaily

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Sclc Clinical Trials.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

6 distinct publisher/source names are currently connected to this entity page.